NEW YORK, June 15, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

India Biotechnology in India Industry

http://www.reportlinker.com/p0553099/India-Biotechnology-in-India-Industry.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Disc

This report analyzes the market for Biotechnology in India in US$ million by the following Key Sectors – Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial, Bioinformatics, and Bio-Services. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 103 companies including many key and niche players such as Advanced Enzymes Technologies Ltd., Ajeet Seeds Ltd., Anthem BioSciences Pvt. Ltd., Bharat Biotech International Limited, Bharat Serums and Vaccines Ltd., Biocon Limited, Syngene International Limited, Dr. Reddy's Laboratories Ltd., Ecron Acunova, Eli Lilly and Company (India) Pvt. Ltd., GlaxoSmithKline Pharmaceuticals Ltd., Indian Immunologicals Ltd., Jubilant Life Sciences Limited, Krishidhan Seeds Private Limited, Lambda Therapeutic Research Ltd., Mahyco, Max Neeman, Monsanto, Novo Nordisk India Pvt. Ltd., Novozymes South Asia Pvt. Ltd., Nuziveedu Seeds Pvt. Ltd., Ocimum Biosolutions Ltd., Panacea Biotec Ltd., Piramal Healthcare Limited, Quintiles India, Rasi Seeds (P) Ltd., Reliance Life Sciences, Serum Institute of India Ltd., Shantha Biotechnics Limited, SIRO Clinpharm, Strand Life Sciences, Veeda Clinical Research Limited, and Vimta Labs Limited. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

1. NTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Data Interpretation & Reporting Level 3

Quantitative Techniques & Analytics 3

Product Definition and Scope of Study 3

Bio-Pharmaceuticals 4

Bio-Agriculture 4

Bio-Industrial 4

Bioinformatics 4

Bio-Services 4

2. OUTLOOK 5

Current & Future Analysis 5

Recession and Foreign Exchange Rate Decelerate Industry Growth 6

Industry Emerges Strong Following Recession 6

Brighter Prospects Ahead for the Indian Biotech Industry 6

3. INDUSTRY OVERVIEW 7

SWOT Analysis 7

Diversity - Key Strength for the Industry 8

Major Sectors in the Indian Biotechnology Industry 8

Government Support for Biotech Innovation - A Boost for the

Industry 9

Challenges Ahead 9

Concerted Efforts are On to Find a Way Out 10

Major Industry-Specific Advantages of the Indian Biopharma Sector 10

Competition 11

Table 1: Leading Biotech Companies in India by Revenues:

2009-10 (includes corresponding Graph/Chart) 11

Table 2: Leading Domestic Biotech Companies in India by

Revenues: 2009-10 (includes corresponding Graph/Chart) 12

Exports - A Major Market for Indian Biotech Industry 12

Table 3: Export Revenues of Indian Biotech Industry by Sector

(2008-09 & 2009-10): Export Value in US$ Million for

Bio-Pharma, Bio-Services, Bio-Agri, Bio-Industrial, and

Bioinformatics (includes corresponding Graph/Chart) 13

Table 4: Biotechnology Industry Export Revenues as a

Percentage Share of Total Segment Revenues: 2009-10 (includes

corresponding Graph/Chart) 13

Analysis by Region 14

Western Region's Domination Continues in Revenue Terms,

Mumbai Moves to the Top 14

Table 5: Leading States in the Indian Biotech Industry by

Revenues: 2009-10 (includes corresponding Graph/Chart) 14

Table 6: Leading Cities In the Indian Biotech Industry by

Revenues: 2009-10 (includes corresponding Graph/Chart) 15

Karnataka Embarks on Further Growth Plans; Other Regions Join

the League 15

4. ISSUES AND TRENDS 16

Government Support to the Biotechnology Sector Surges 16

Recognizing the Importance of Right Educational System 16

Need for a Streamlined Regulatory Process Continues 17

Angel Funding - Still Eluding the Sector 17

More Countries Look to India for Outsourcing 17

China and India - Competing for Biotech Investments 18

5. BIO-PHARMACEUTICALS IN INDIA 19

Current and Future Analysis 19

Table 7: Indian Bio-Pharmaceuticals Market by Segment (2010):

Percentage Share Breakdown for Vaccines, Diagnostics,

Therapeutics, and Others (includes corresponding Graph/Chart) 19

Competitive Landscape of the Biopharma Sector 20

Table 8: Leading BioPharma Companies in India by Revenues:

2009-10 (includes corresponding Graph/Chart) 20

Market Analysis by Segment 21

Vaccines 21

Vaccines to Spearhead Growth in the Indian BioPharma Market 21

Demand for Vaccines to Surge 21

India to Emerge as a Global Hub for Vaccines 22

Diagnostics 22

India Diagnostics Market - An Overview 22

Table 9: Leading Players in the Indian Diagnostics Market

by Revenues: Market Share Breakdown of Revenues for Tulip,

TransAsia Biomedical, Bayer, Span Diagnostics, and Others

(2010) (includes corresponding Graph/Chart) 22

Indian Diagnostics Industry - Stifled with High Competition 23

Diagnostic Centers Expand Test Menu to Beat Competition 23

Bio-Therapeutics - Going Strong 23

Overseas Giants Dominate the Insulin Market 23

Plasma Proteins - A Potential Growth Area 24

mAbs Gain Prominence in the Biopharma Industry 24

Market Trends 25

Climbing Up the Value Chain 25

Domestic Market to Provide Impetus to Bio-Pharma Industry Growth 25

Biosimilars to Offer Tremendous Prospects for Indian Players 26

Table 10: Indian Market for Biosimilars by Drug Class

(2009): Revenues for Insulin, EPO, Interferon,

Streptokinase, and G-CSF (includes corresponding

Graph/Chart) 26

Biopharmaceutical Pipeline Growth Continues 26

r-DNA Biopharmaceuticals Cleared for Pre-Clinical Studies:

2009-10 27

Indian Firms Embrace Strategic Partnerships to Enter Biotech

Industry 28

Indian Biopharma Market Luring Overseas Players 28

Indian Pharma Companies on a Co-Development Spree 29

Vaccines Remain the Center of Focus in Indian BioPharma 29

Brighter Prospects Ahead in Original Drug Development 30

Myriad Factors Drive Growth in the Indian BioPharma Sector 30

Pharma Companies Shift Focus to BioPharma 31

6. BIO-AGRICULTURE IN INDIA 32

Current And Future Analysis 32

Indian Bio-Agriculture Industry - An Overview 32

Select Biotech Crops in India Under Field Trials: 2008 33

Transgenic Crops Cleared for Limited Field Trials: 2009-10 34

India - A Leading Adopter of Biotech Crops Worldwide 34

Bio-Agri Treads On A Fast-Track Growth Path 34

Public and Private Sector Participation in Bio-Agri Research 35

Bt Cotton - A Major Success in India 35

Indian Farmers Increasingly Embrace Bollgard II Cotton 36

Monsanto And Mahyco to Battle Out Pink Bollworm Resistance in

Bollgard - I 36

Move to Commercialize Bt Brinjal Draws Major Controversy 36

Government Retreats, Imposes Moratorium on Launch of Bt Brinjal 37

Moratorium on Bt Brinjal Launch, A Setback to the Industry? 37

Establishment of BRAI Also Faces the Heat of Opponents 38

Stark Criticism Compels India to Establish Transparent

Administration of Biotech Procedures 38

Bio-Diesel Market - Still in Infancy 39

Bio-Fertilizers and Bio-Pesticides Market - An Overview 39

Competitive Scenario in the Bio-Agri Sector 40

Table 11: Leading Bio-Agriculture Companies in India by

Revenues: 2009-10 (includes corresponding Graph/Chart) 40

7. BIO-INDUSTRIAL SECTOR IN INDIA 41

Current & Future Analysis 41

A Peek Into The Indian Bio-Industrial Sector 41

Indian Bio-Industrial Sector - Fairly Concentrated 41

Table 12: Leading Players in the Indian Bio-Industrial Sector

(2009-10): Market Share as Percentage of Revenues for

Novozymes, Advanced Enzyme Technologies, and Others (includes

corresponding Graph/Chart) 42

8. BIOINFORMATICS 43

Current & Future Analysis 43

Indian BioInformatics Market Posts Sluggish Growth 43

9. BIO-SERVICES 44

Current And Future Analysis 44

Indian Bio-Services Market Bustling with Activity 44

India - A Growing Hub for Clinical Trials 45

Competitive Scenario 45

Table 13: Leading Biotechnology Services Companies in India

By Revenues (2009-10) (includes corresponding Graph/Chart) 45

10. REGULATORY SETUP 46

Regulatory Evolution in the Country 46

Department of Biotechnology 46

Public Sector Undertakings under the DBT 46

Autonomous Institutions operating under the DBT 46

Roles and Responsibilities of DBT 47

Various Committees Operating Under the DBT and MoEF 47

GEAC or the Genetic Engineering Approval Committee 47

Review Committee on Genetic Manipulation 47

Institutional Bio-Safety Committee 47

Recombinant DNA Advisory Committee 48

Central Drugs Standard Control Organization 48

Select Acts, guidelines and regulations that govern the

biotechnology industry in India 48

Agencies Supporting and Financing Biotechnology Research in

India 49

New Regulatory Framework on the Horizon 49

National Biotechnology Strategy 49

11. INDUSTRY INFRASTRUCTURE 50

Biotech and Science Parks in the Country 50

Select Biotech and Science Parks in India 50

Major Research Institutes in India 50

Select Key Research Institutes in India 50

Autonomous Biotechnology Institutes in India 51

12. BIOTECHNOLOGY - AN OVERVIEW 52

Biotechnology 52

A Peek into the History of Biotechnology 52

Select Major Applications of Biotechnology 52

Medicine 53

Pharmacogenomics 53

Biopharmaceuticals 53

Genetic Testing 53

Gene Therapy 54

Cloning 54

Agriculture 54

Bioremediation and Biodegradation 54

13. PRODUCT APPROVALS/LAUNCHES 55

Panacea Biotec to Introduce PacliALL 55

Gene Logic Rolls Out ASCENTA System Version 4.0 55

Bharat Biotech International Unveils HNVAC™ H1N1 Swine Flu

Vaccine 55

Strand Scientific Intelligence Introduces Avadis NGS 56

Dr Reddy's Rolls Out Generic Darbepoetin Alfa Drug, Cresp® 56

BD Biosciences and ReaMetrix Unveil New Reagents 56

Serum Institute of India Rolls Out Nasovac H1N1 Vacccine in India 56

Ocimum Biosolutions Introduces Biotracker™ 57

Novo Nordisk Launches Antidiabetic Drug, Victoza in India 57

Cadila Healthcare Launches Vaxiflu-S 57

Ocimum Biosolutions Introduces qRT-PCR Services 58

Wockhardt Rolls Out Biotechnology Products 58

Intas Biopharma Launches Borviz in India 58

Bharat Biotech International Unveils COMVAC5® Vaccine 58

14. RECENT INDUSTRY ACTIVITY 59

Bharat Biotech Commences Phase III Clinical Trial with THR-100 59

Bayer Teams Up with Zydus for Joint Venture in India 59

Qiagen Establishes Qiagen India 59

Ecron Acunova Expands Capacity at Mangalore Clinical Research

Center 60

IndianOil Inks MOU with LanzaTech 60

Dow AgroSciences and GVK Biosciences Discover New Compound 60

Ecron Acunova Establishes Joint Venture CRO in Thailand 60

Praj Industries Enters into Partnership with Qteros 61

Mavens Biotech to Venture into Biotech Education 61

Aurobindo Pharma to Divest Stake in Its Chinese Subsidiary 61

Evolvence India Life Sciences Takes Over Stake in Fermenta

Biotech 62

Strides Arcolab to Take Over 70% Stake in Inbiopro Solutions 62

Rallis Acquires Majority Stake in Metahelix 62

Ocimum Secures US$8 Million Funding for Future Growth 62

Dr. Reddy's to Purchase US Penicillin Facility and Product

Rights from GSK 63

Life Technologies to Take Over Labindia 63

Biocon Enters into Strategic Global Agreement with Pfizer 63

Intas Biopharma to Ink Out-Licensing Deal with Japanese Firm 64

Biocon Limited and CMI Enter into Immunology Research

Collaboration 64

Biocon Signs Contract with Teleradiology Solutions 64

Jubilant Organosys Changes Name to Jubilant Life Sciences 65

Jubilant Inks CRAMS Deal with a US Firm 65

MSCCC and Strand Life Sciences Ink MOU for Translational

Cancer Research 65

Lohmann Animal Health Enters into Joint Venture with Suguna 66

International Stem Cell Inks a Distribution Agreement with

Sristi Biosciences 66

BioServe Biotechnologies Receives NABL Accreditation for GMO

Testing 66

Indian Immunologicals to Develop Oral Cervical Cancer Vaccine 66

Piramal Healthcare to Take Over the Assets of BioSyntech 67

Ocimum Biosolutions to Offer BioIT Consulting Services 67

Zydus Obtains DCGI Clearance for Initiating Phase I Trials on

Zyog1 67

Krishidhan Establishes Subsidiary in Europe 68

Biocon Limited Inks Supply Deal with Optimer Pharmaceuticals 68

Australia to Grant Research Funding to India 68

Ocimum Biosolutions and Jivan Biologics Enter into Partnership 68

Stempeutics Completes Phase I/II Study of Stemepucel-CLI Stem

Cell Product 69

Ranbaxy Enters into Alliance with Pfenex 69

Syngene Collaborates with Endo Pharmaceuticals 69

Panacea Biotech Obtains Financial Assistance from DBT for

Vaccine Development 69

M. D. Anderson Cancer Center Selects Biotracker™ of Ocimum

Biosolutions 70

GVK Biosciences Establishes New Clinical Pharmacology Unit 70

Delta Embedded Solutions to merge with Bio-Analytical

Technologies 70

Clingene Seeks Alliance with SIRO Clinpharm 71

Biocon Investments in Malaysian Biotech Market 71

Ranbaxy to Foray into Vaccines Market through Acquisition of

Biovel's Assets 71

Clinigene International Deploys PheedIt Solution of SAS 72

Bioseed Research India Inks Strategic Partnership Agreement

with KeyGene 72

PRAJ Partners with Novozymes 73

Mylan sells stake in Concord Biotech 73

Vibha Seeds Sets Up Seed Facility in Andhra Pradesh 73

Bayer Cropscience Inks Research Cooperation Agreement with GVK

Biosciences 73

Millipore Acquires Outstanding Stake of its Joint Venture in

India 74

Avesthagen Forms Joint Venture with Limagrain 74

Indus Biotech Receives HIV Controller Status for IND02 from FDA 74

Bharat Biotech Commences Construction at Konark Knowledge Park

in Orissa 74

International Biotech Park to Forge International Alliances 75

Merck Acquires Bangalore Genei 75

Bharat Biotech Secures International Patents for Lysostaphin 75

Genzyme Inks MoU with NIPER for Offering Biotechnology

Fellowships 75

Biocon Enters into Agreement with Amylin Pharmaceuticals 76

WHO and DCGI Direct Serum Institute of India to Focus on H1N1

Vaccine 76

Acoris Research Enters into Strategic Partnership with c-LEcta 76

Serum Institute of India to Expedite Vaccine Development 76

Sanofi Aventis Acquires Shantha Biotechnics 77

Biocon Inks a Strategic Collaboration Agreement with Mylan 77

Lonza to Invest in Genome Valley for Two Major Projects 77

Bio-Rad Laboratories Integrates DiaMed Scientific Technologies

in India 78

Syngene Enters into Alliance with DuPont Crop Protection 78

Emami Biotech Limited and Calcutta Tramways Company Ink MoU 78

TCG Lifesciences and Pfizer Extend Master Services Agreement 78

Biological E Commences Operations at New Campus 79

Syngene Enters into Partnership with Sapient 79

Intas Biopharmaceuticals Inks MoU with Government of Gujarat 80

Emami's Bio-Diesel Obtains SGS Certification 80

Ocimum Biosolutions Enters into Partnership with NuGEN 80

Biocon Collaborates with Abraxis to Introduce Abraxane in India 81

Intas Biopharmaceuticals Takes Over BPD 82

Bharat Biotech Completes Phase I/II Clinical Trials for 116E

Oral Rotavirus Vaccine 82

Intas Biopharmaceuticals to Commercialize Gefitinib in India 82

Avesthagen Inks LoI with ShigaMediX 83

Ranbaxy Signs Collaborative Research Agreement with DBT 83

Veeda Establishes Global Oncology Contract Research Organization 83

Avesthagen Signs Framework Agreement with DuBiotech 83

Biocon Buys Majority Stake in German Company 83

Monsanto India to Sell Butachlor & Alachlor Businesses to

Sinochem International 84

Biocon Signs Strategic Partnership Agreement with IATRICa 84

Intas Pharmaceuticals to Sell Biotechnology Products in GCC 84

15. FOCUS ON SELECT LEADING PLAYERS 85

Advanced Enzymes Technologies Ltd. 85

Ajeet Seeds Ltd. 85

Anthem BioSciences Pvt. Ltd. 85

Bharat Biotech International Limited 86

Bharat Serums and Vaccines Ltd. 86

Biocon Limited 87

Syngene International Limited 88

Dr. Reddy's Laboratories Ltd 88

Ecron Acunova 89

Eli Lilly and Company (India) Pvt. Ltd. 89

GlaxoSmithKline Pharmaceuticals Ltd. 89

Indian Immunologicals Ltd. 90

Jubilant Life Sciences Limited 90

Krishidhan Seeds Private Limited 91

Lambda Therapeutic Research Ltd. 91

Mahyco 92

Max Neeman 92

Monsanto 92

Novo Nordisk India Pvt. Ltd. 93

Novozymes South Asia Pvt. Ltd. 93

Nuziveedu Seeds Pvt. Ltd. 94

Ocimum Biosolutions Ltd. 94

Panacea Biotec Ltd. 95

Piramal Healthcare Limited 95

Quintiles India 96

Rasi Seeds (P) Ltd. 96

Reliance Life Sciences 97

Serum Institute of India Ltd. 97

Shantha Biotechnics Limited 98

SIRO Clinpharm 98

Strand Life Sciences 98

Veeda Clinical Research Limited 99

Vimta Labs Limited 99

16. MARKET ANALYTICS 100

Table 14: Indian Recent Past, Current & Future Analysis for

Biotechnology Industry by Sector - Bio-Pharmaceuticals,

Bio-Agriculture, Bio-Industrial, Bioinformatics, and

Bio-Services Markets Independently Analyzed with Annual Sales

in US$ Million for Years 2009 through 2017 (includes

corresponding Graph/Chart) 100

Table 15: Indian Historic Review for Biotechnology Industry by

Sector- Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial,

Bioinformatics, and Bio-Services Markets Independently

Analyzed with Annual Sales in US$ Million for Years 2003

through 2008 (includes corresponding Graph/Chart) 101

Table 16: Indian 15-Year Perspective for Biotechnology

Industry by Sector - Percentage Breakdown of Dollar Sales for

Bio-Pharmaceuticals, Bio-Agriculture, Bio-Industrial,

Bioinformatics, and Bio-Services Markets for Years 2003, 2010

and 2017 (includes corresponding Graph/Chart) 102

Table 17: Indian Recent Past, Current & Future Analysis for

Bio-Pharmaceuticals by Segment - Vaccines, Diagnostics,

Therapeutics, and Others Markets Independently Analyzed with

Annual Sales in US$ Million for Years 2009 through 2017

(includes corresponding Graph/Chart) 103

Table 18: Indian Historic Review for Bio-Pharmaceuticals by

Segment - Vaccines, Diagnostics, Therapeutics, and Others

Markets Independently Analyzed with Annual Sales in US$

Million for Years 2003 through 2008 (includes corresponding

Graph/Chart) 104

Table 19: Indian 15-Year Perspective for Bio-Pharmaceuticals

by Segment - Percentage Breakdown of Dollar Sales for

Vaccines, Diagnostics, Therapeutics, and Others Markets for

Years 2003, 2010 and 2017 (includes corresponding Graph/Chart) 105

COMPETITIVE LANDSCAPE

Total Companies Profiled: 103 (including Divisions/Subsidiaries - 112)

------------------------------------------

Region/Country Players

------------------------------------------

Asia-Pacific (Excluding Japan) 112

------------------------------------------

To order this report:

Drug Discovery and Development Industry: India Biotechnology in India Industry

Drug Discovery and Development Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker